Artificial IntelligenceRecap AI Circular Economy Conference 2026The AI Circular Economy Conference 2026, organised by nova-Institute, brought together 116 participants from 15 countries in Cologne and online to explore the transformation of the chemical and materials … more ➔
Life Sciences Innovations Made in EuropeResearch and Innovation as a Competitive Advantage – Legal framework for Life Sciences made in EuropeResearch and innovation are considered key resources for European competitiveness – and essential location factors for research-intensive industries such as the Life Sciences. The European Union is … more ➔
CDMO3PBIOVIAN and INC partner to expand access to oncology treatments in Colombia through biosimilar development3PBIOVIAN consolidates its position as a trusted partner for the development and manufacturing of complex biological products, combining scientific excellence, regulatory expertise, and strong social … more ➔
New England BiolabsThe Bridge to your successCustomized Enzymes and Reagents from New England Biolabs. Creating the right partnership is essential when pioneering a new life science product. more ➔
BioDlinkDrug developmentSolutions-Based Thinking: BioDlink’s Model for Successful CDMO PartnershipsIn an interview with European Biotechnology Magazine during J.P. Morgan Week in San Francisco, Dr. Jian Zhang, Acting CEO of BioDlink, explains how a partnership-first approach and deep ADC expertise … more ➔
RegulatorySFDA vs EMA: What Biotech Leaders need to KnowAs the regulatory strategy becomes a boardroom-level concern for biotech executives pursuing global expansion, knowing how the Saudi Food and Drug Authority (SFDA) and the European Medicines Agency (EMA) … more ➔
Pharmahungary GroupDrug DiscoverymiRNA discovery & development platformPharmahungary Group (PH) developed miRNAtarget, a miRNA discovery software tool based on miRNA-mRNA molecular networks. PH holds patent families on 4 cardio-protective microRNAs families (protectomiRs) … more ➔
Merck KGaA, Darmstadt GermanyPegylated TherapiesSelecting a CDMO for Custom Activated PEGsThis article examines the critical success factors for PEGylated therapies and the decision-making process for when a custom PEG may be warranted rather than an off-the-shelf solution. The essential … more ➔
Oncology ResearchTiny Models, Big ImpactOrganoids are reshaping cancer R&D by providing more accurate, patient-relevant models than classical methods. By bridging the gap between preclinical and early clinical stages, they enable patient-centric … more ➔
BIMOVIS GmbHBIMOVISUnlock the Power of Structural BiologyIn this interview Dr. Martin Stieler, founder and CEO of BIMOVIS, introduces his company and the importance of structural biology in biotech and pharmaceutical industries, and highlights how BIMOVIS … more ➔
BioDlink
Pharmahungary Group
Merck KGaA, Darmstadt Germany
BIMOVIS GmbH